NR4A2 and familial pancreatic carcinoma: Results of NURR1 knockdown or treatment with the NURR1 antagonist 1,1-bis(3 ́-indolyl)-1-(p-chlorophenyl)methane (C-DIM 12) demonstrated that NURR1 was prooncogenic in pancreatic cancer cells and regulated cancer cell and tumor growth and survival.